Aptinyx Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Aptinyx Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8010861
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月20日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aptinyx Inc (Aptinyx), formerly Enarex, Inc., is a biopharmaceutical company which focuses on the discovery and development of novel therapies for the treatment of brain and nervous system disorders. The company has a robust chemistry library with small molecule compounds which are designed to elegantly modulate the NMDA receptor. Aptinyx primarily focuses on developing NMDA modulators to treat diseases with unmet medical needs. It holds compounds in early and advanced stages of preclinical development for various indications such as depression, neuropathic pain, migraine and traumatic brain injury, among others. The company was spun out of Naurex Inc. Aptinyx is headquartered in Evanston, Illinois, the US.

Aptinyx Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aptinyx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aptinyx Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aptinyx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aptinyx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Aptinyx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Aptinyx Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Aptinyx Raises USD70 Million in Series B Financing 11
Aptinyx Raises USD65 Million in Series A Venture Financing 13
Aptinyx Raises Funds through Seed Financing 15
Partnerships 16
Aptinyx to Enter into Research Partnership with Allergan 16
Equity Offering 17
Aptinyx Spin Off from Naurex 17
Aptinyx Inc – Key Competitors 18
Aptinyx Inc – Key Employees 19
Aptinyx Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
Dec 07, 2017: Aptinyx Bolsters Executive Leadership Team With Appointment of Andy Kidd as Chief Commercial Officer 21
Product News 22
11/14/2016: Aptinyx to Present Data for NYX-2925 in Models of Neuropathic Pain and Traumatic Brain Injury at Neuroscience 2016 22
11/10/2016: Aptinyx Awarded Up to $2.85 Million in NIH Grants to Research NMDA Receptor Modulation for the Treatment of Neuropathic Pain and AgeRelated Cognitive Decline 23
Product Approvals 24
Sep 13, 2016: Aptinyx Receives FDA Fast Track Designation for Development of NYX-2925 as Treatment for Neuropathic Pain Associated with Diabetic Peripheral Neuropathy 24
Clinical Trials 25
Jul 13, 2016: Aptinyx Initiates Dosing in Phase 1 Clinical Study of Lead NMDA-Receptor Modulator, NYX-2925 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Aptinyx Inc, Pharmaceuticals & Healthcare, Key Facts 2
Aptinyx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aptinyx Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aptinyx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aptinyx Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Aptinyx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Aptinyx Raises USD70 Million in Series B Financing 11
Aptinyx Raises USD65 Million in Series A Venture Financing 13
Aptinyx Raises Funds through Seed Financing 15
Aptinyx to Enter into Research Partnership with Allergan 16
Aptinyx Spin Off from Naurex 17
Aptinyx Inc, Key Competitors 18
Aptinyx Inc, Key Employees 19

★海外企業調査レポート[Aptinyx Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Swelect Energy Systems Ltd (SWELECTES):電力:M&Aディール及び事業提携情報
    Summary Swelect Energy Systems Ltd (SESL), formerly Numeric Power Systems Ltd is an energy company that manufactures and markets renewable energy products and iron and steel products. The company’s renewable energy products include solar pv modules, solar inverter, solar water pump and energy effici …
  • GTx Inc (GTXI):製薬・医療:M&Aディール及び事業提携情報
    Summary GTx Inc (GTx) is a biopharmaceutical company that discovers, develops and commercializes novel targeted hormonal therapies. It develops small molecules that targets hormone pathways for the treatment of various cancers including breast and prostate cancer; and other serious medical condition …
  • Tangent Energy Solutions, Inc.:企業の戦略的SWOT分析
    Tangent Energy Solutions, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Dialog Semiconductor plc (DLG):電力:M&Aディール及び事業提携情報
    Summary Dialog Semiconductor plc (Dialog) is a supplier of motor control ICs for automotive applications. The company’s product portfolio includes integrated power management, AC/DC power conversion, solid state lighting (SSL), Bluetooth low energy, mixed signal integrated circuits (ICs), hand-held …
  • Bayer HealthCare Pharmaceuticals:医療機器:M&Aディール及び事業提携情報
    Summary Bayer HealthCare Pharmaceuticals (Bayer Healthcare), formerly Bayer Schering Pharma AG, a subsidiary of Bayer AG, is the pharmaceutical company that develops, manufactures and markets prescription products in the areas of general medicine and specialty medicine. The company offer prescriptio …
  • Irish Life Assurance plc:企業の戦略・SWOT・財務分析
    Irish Life Assurance plc - Strategy, SWOT and Corporate Finance Report Summary Irish Life Assurance plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Xvivo Perfusion AB (XVIVO):企業の財務・戦略的SWOT分析
    Summary Xvivo Perfusion AB (Xvivo) is a medical technology company that provides organ transplantation solutions. The company develops organ preservation products such as perfadex and silicone tubing sets and normothermic perfusion products. It offers normothermic perfusion products such as STEEN so …
  • Smith & Nephew Plc (SN.):医療機器:M&Aディール及び事業提携情報
    Summary Smith & Nephew Plc (Smith & Nephew) is a medical technology company that develops, manufactures and markets medical devices for use in orthopaedic reconstruction and trauma, sports medicines and advanced wound management. The company offers its products in various categories including Sports …
  • Paz Oil Co Ltd (PZOL):企業の財務・戦略的SWOT分析
    Paz Oil Co Ltd (PZOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • EnergySolutions, LLC:電力:M&Aディール及び事業提携情報
    Summary EnergySolutions, LLC (EnergySolutions) is a nuclear services company. It provides a full range of decommissioning and decontamination services to shut down nuclear power plants. The company offers services for the decommissioning and remediation of nuclear sites and facilities, management of …
  • Kesoram Industries Ltd:企業の戦略・SWOT・財務情報
    Kesoram Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Kesoram Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Jamnica dd:企業の戦略・SWOT・財務分析
    Jamnica dd - Strategy, SWOT and Corporate Finance Report Summary Jamnica dd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Odebrecht S.A.:企業の戦略・SWOT・財務情報
    Odebrecht S.A. - Strategy, SWOT and Corporate Finance Report Summary Odebrecht S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Abeona Therapeutics Inc (ABEO):企業の財務・戦略的SWOT分析
    Abeona Therapeutics Inc (ABEO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Profarma Distribuidora de Produtos Farmaceuticos SA (PFRM3):企業の財務・戦略的SWOT分析
    Profarma Distribuidora de Produtos Farmaceuticos SA (PFRM3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the comp …
  • Nufarm Ltd (NUF):企業の財務・戦略的SWOT分析
    Nufarm Ltd (NUF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • SMBC Trust Bank Private Banking:企業の戦略・SWOT・財務情報
    SMBC Trust Bank Private Banking - Strategy, SWOT and Corporate Finance Report Summary SMBC Trust Bank Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Interim HealthCare Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Interim HealthCare Inc (IHC), formerly Medical Personnel Pool Inc, is a healthcare service provider that offers home care and home health care services. The center provides senior care, pediatric nursing and physical, occupational and speech therapy. Its specialized homecare services include …
  • Sligro Food Group N.V.:戦略・SWOT・企業財務分析
    Sligro Food Group N.V. - Strategy, SWOT and Corporate Finance Report Summary Sligro Food Group N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Finance Wales plc:企業のM&A・事業提携・投資動向
    Finance Wales plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Finance Wales plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆